Skip to content

Efficacy trial of ingestion of the developmental code USRP-003

Efficacy trial of ingestion of the developmental code USRP-003 - Efficacy trial of ingestion of the developmental code USRP-003

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000033923
Enrollment
20
Registered
2018-08-31
Start date
2018-09-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Daily ingestion of four sugar-coated USRP-003 pills at bed time for 4 weeks. After about 4 weeks washout period, daily ingestion of four sugar-coated placebo pills at bed time for 4 weeks. Daily inges

Sponsors

Kao Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -Healthy men and women -Subjects who have urination more than twice in sleep

Exclusion criteria

Exclusion criteria: -Subjects with severe illness -Subjects who take one of the medicine of urinary, sleep and mental disorder -Subjects who have had one of the diseases of brain injury, spinal cord injury, urinary disorder, sleep disorder and mental disorder -Subjects who underwent the surgery of urinary functions -Subjects who drink water over 3L a day -Subjects who regularly take supplements related to urination, sleep or stress -Subjects who have allergy to foods or medicine -Subjects who have menstruation -Subjects who have an unsteady lifestyle -Subjects who have bad condition -Subjects who participate in the other examinations which have an influence on this examination -Subjects judged inappropriate to participate in this study by the principle investigator

Design outcomes

Primary

MeasureTime frame
Efficacy of the 4 weeks ingestion of the developmental code USRP-003 on the number of urination and so on in sleep.

Countries

Japan

Contacts

Public ContactNaoya Kitamura

Kao Corporation Biological Science Research

kitamura.naoya@kao.com+81-285-68-7458

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026